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As highly conserved signaling cascades of multicellular 
organisms, Wnt and Hippo pathways control a wide range of 
cellular activities, including cell adhesion, fate determination, 
cell cycle, motility, polarity, and metabolism. Dysregulation of 
those pathways are implicated in many human diseases, 
including cancer. Similarly to -catenin in the Wnt pathway, 
the YAP transcription co-activator is a major player in Hippo. 
Although the intracellular dynamics of YAP are well-known to 
largely depend on phosphorylation by LATS and AMPK 
kinases, the molecular effector of YAP cytosolic translocation 
remains unidentified. Recently, we reported that the 
Dishevelled (DVL), a key scaffolding protein between 
canonical and non-canonical Wnt pathway, is responsible for 
nuclear export of phosphorylated YAP. The DVL is also 
required for YAP intracellular trafficking induced by E-cadherin, 
-catenin, or metabolic stress. Note that the p53/LATS2 and 
LKB1/AMPK tumor suppressor axes, commonly inactivated in 
human cancer, govern the reciprocal inhibition between DVL 
and YAP. Conversely, loss of the tumor suppressor allows 
co-activation of YAP and Wnt independent of epithelial 
polarity or contact inhibition in human cancer. These 
observations provide novel mechanistic insight into (1) a tight 
molecular connection merging the Wnt and Hippo pathways, 
and (2) the importance of tumor suppressor contexts with 
respect to controlled proliferation and epithelial polarity 
regulated by cell adhesion.  [BMB Reports: Perspective 2018; 
51(9): 425-426]
The Human Genome Project revealed a remarkably small 
number of ligand-mediated signaling pathways, such as the 
Wnt and TGF- superfamily, involved in a biologically diverse 
range of human diseases. Thus, molecular components within 
a limited number of pathways are dynamically interacting into 
higher order signaling networks that dictate the biological 
outcomes of pathway activity. Typically, post-translational 
modification, molecular interaction, and intracellular trafficking 
of signaling molecules account for diverse biological aspects 
of a pathway.
The Hippo signaling has emerged as a critical regulator of 
organ size, tissue homeostasis, and patterning underlying 
cell-to-cell contact inhibition, loss of Hippo leading to organ 
overgrowth and cancer proliferation. The intracellular core of 
the Hippo pathway consists of a kinase cascade regulating 
nuclear-cytoplasmic shuttling of YAP (Moroishi T et al (2015) 
Nat Rev Cancer 15, 73-79). The Lats1 or Lats2 are well-known 
kinases resulting in cytoplasmic translocation of YAP. In the 
normal physiologic context of epithelial cells, adherens and 
tight junctions mediate contact inhibition of cell growth in a 
Lats kinases-dependent manner. Interestingly, metabolic 
starvation relocates nuclear YAP into cytoplasm via AMPK (Mo 
JS et al (2015) Nat Cell Biol 17, 500-510). While the phos-
phorylation-dependent YAP shuttling constitutes a core of the 
Hippo pathway, the molecular effector by which YAP 
translocates has until now been unknown. 
Hyperactivation of the Wnt pathway constitutes a key 
feature in human cancer, including colorectal cancer, which 
has frequent APC or -catenin mutation. The importance of the 
Wnt pathway is also highlighted by its coordinate control of 
the transcriptional program underlying Snail-mediated EMT. In 
canonical Wnt signaling, well-known scaffolding proteins such 
as APC, Axin and DVL function as critical intracellular 
regulators of -catenin dynamics. While the Axin is regulated 
by Wnt co-receptor LRP5/6, the DVL acts directly downstream 
of Frizzled receptors. As an essential component of the Wnt 
pathway, the enigmatic DVL transduces signals into three 
separate signaling branches, the canonical (-catenin depen-
dent), non-canonical (-catenin independent), and Wnt-Ca＋＋ 
pathways. DVL interacts with a wide range of partner proteins, 
revealing its diverse functions in areas including cellular 
differentiation, inflammation, neurodegeneration, cell polarity 
and social behavior. DVL consists of three homolog genes in 
mammal, DVL1, DVL2, and DVL3. These multifunctional 
proteins mediate complex signal transduction via conserved 
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Diagram 1. Schematic model for phosphorylation-dependent YAP 
translocation by DVL. When the Hippo pathway is activated, 
Lats1/2-phosphorylated YAP leads to inhibition of the nuclear 
transcriptional activity through cytoplasmic translocation. The phos-
phorylated YAP is exported by DVL into cytoplasmic space. Note 
that p53 and LKB1/AMPK tumor suppressors maintain Lats1/2 
activities which are responsible for YAP trafficking controlled by 
the contact inhibition from tight/adherens junctions or metabolic 
regulation. 
domains: the DIX and PDZ domains serve for the canonical 
Wnt pathway while the PDZ and DEP domains serve for 
non-canonical Wnt. Although DVL2 has been studied in 
developmental contexts due to its ubiquitous abundance in 
various tissues, we found that the DVL3 isoform is mainly 
expressed in human cancer cells in terms of transcript in 
clinical samples and protein abundance in cancer cell line 
panels. 
Given the importance of contact inhibition in multicellular 
organisms, the reciprocal regulation between Wnt and Hippo 
is of central interest in development as well as in human 
cancer. While large bodies of recent studies have focused on 
the role of YAP in Wnt suppression via DVL, a ligand-specific 
receptor of Hippo has not yet been found. We therefore raised 
the hypothesis that DVL harbors a function which specifically 
enables YAP to tightly connect Hippo and Wnt. Indeed, DVL 
scaffolding protein drives the nuclear export of phosphorylated 
YAP. The DVL contains conserved nuclear export signals (NES, 
M/LxxLxL) located next to the DEP domain, the NES being 
responsible for YAP cytoplasmic translocation. Importantly, 
the DVL is required for YAP cytoplasmic translocation induced 
by tight contact inhibition, E-cahderin, -catenin or AMPK 
activation, indicating that Wnt scaffolding protein DVL is an 
important shuttling effector in the Hippo pathway.  
The tumor suppressors p53 and LKB1 are most frequently 
inactivated in human cancer. The Lats2 is one of the 
transcriptional targets of p53, and AMPK is a well-known 
downstream cascade of LKB1. Thus, the loss of p53 and LKB1 
in cancer abolishes Lats2 and AMPK activities essentially 
required for DVL’s role in YAP trafficking. Note that p53 
transcription activity also suppresses canonical Wnt and the 
Snail-mediated EMT program (Kim NH et al (2011) Sci Signal 
4, ra71). Therefore, the intact tumor suppressor governs the 
reciprocal regulation between Wnt and Hippo, resulting in 
balanced cell migration and controlled proliferation by contact 
inhibition. In turn, loss of tumor suppressor in human cancer 
abolishes DVL’s role in YAP translocation and allows 
consistent activation of Wnt and nuclear YAP via feed-forward 
activation. Note that Wnt ligands activate YAP via the 
G/Rho/Lats1/2 cascade (Park HW et al (2015) Cell 162, 
780-794). Given the YAP phosphorylation-dependent interaction 
with DVL, Wnt ligands (such as Wnt1 or Wnt 3a) dissociate 
DVL-YAP interaction, resulting in co-activation of canonical 
Wnt and nuclear YAP activity. Therefore, intact p53 or LKB1 
tumor suppressor function maintains epithelial polarity, 
restricting co-activation of canonical Wnt and nuclear YAP 
activities (Diagram 1). Conversely, hyperactivation of Wnt 
coupled with loss of tumor suppressor constitutes a core 
signaling network, allowing the uncontrolled proliferation and 
metastatic potential of human cancer.  
These observations provide several insights into highly 
conserved signaling pathways coupled with tumor suppressor 
contexts. First, although the Wnt and Hippo pathways are 
largely regarded as independent, they may be closely linked 
via DVL. Second, the Wnt and Hippo comprise a central core 
signaling, balancing cell growth by contact inhibition and 
migratory potential, such as in wound healing under 
physiologic condition. Lastly, loss of tumor suppressor function 
disrupts DVL’s role in the Hippo pathway allowing the 
feed-forward co-activation of Wnt and YAP commonly 
observed in human cancer. 
In conclusion, this study provides mechanistic insight into 
how the Wnt and Hippo pathways coordinate with each other 
during development and human cancer. Specifically, the Wnt 
scaffolding protein DVL functions as a molecular effector of 
YAP nuclear-cytoplasmic shuttling, being regulated by Hippo 
pathway and metabolic cues. Further study is thus needed to 
identify the role of DVL in epithelial polarity, adhesion and 
metabolism.   
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